Atherosclerosis

Editor's choice

The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease

Sven M Francque

European Cardiology Review 2014;9(1):10–5

Videos

Randomized Placebo-Controlled Trial of Anacetrapib

28 August 2017
Video Case Study: Retrograde CTO PCI of 43 year old male

18 August 2017

Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS study

Josep Gradolí, Verónica Vidal, Adrian JB Brady, et al

European Cardiology Review 2018;13(2):ePub:29 October 2018.

DOI: https://doi.org/10.15420/ecr.2018.12.2
Role of Anti-inflammatory Interventions in Coronary Artery Disease: Understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

Alberto Lorenzatti, Maria Luz Servato

European Cardiology Review 2018;13(1):38–41.

DOI: https://doi.org/10.15420/ecr.2018.11.1
Management of Severe Dyslipidaemia: Role of PCSK9 Inhibitors

Stephen J Nicholls

European Cardiology Review 2018;13(1):9–13.

DOI: https://doi.org/10.15420/ecr.2018.3.2
Cardiovascular Implications of Sphingomyelin Presence in Biological Membranes

Petros Kikas, George Chalikias, Dimitrios Tziakas, et al

European Cardiology Review 2018;13(1):42–5.

DOI: https://doi.org/10.15420/ecr.2017:20:3